home.social

#vertexpharmaceuticals — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #vertexpharmaceuticals, aggregated by home.social.

fetched live
  1. Goldman Sachs Overhauls Conviction Lists, Adding Vertex and Three European Names — BigGo Finance

    Goldman Sachs kicked off September with a sweeping refresh of its highest-conviction stock picks on both sides of…
    #Europe #EU #Adyen #AlbertoGandolfi #Amprion #AndrewBaker #CrineticsPharmaceuticals #European #GoldmanSachs #InteractiveBrokers #MohammedMoawalla #rwe #SalveenRichter #Talanx #VertexPharmaceuticals
    europesays.com/europe/128728/

  2. Jason Coloma: The FTC Killed Our Sanofi Deal. Six Months Later, We Had a Better One. — BigGo Finance

    The Federal Trade Commission does not usually feature prominently in a biotech CEO’s business plan. For Jason Coloma,…
    #France #FR #Europe #EU #Sanofi #APOL1 #AstraZeneca #BridgeBio #FTC #Genentech #JasonColoma #MazeTherapeutics #Parasol(UniversityofMichigan) #Pompedisease #Roche #Shionogi #SLC6A19 #ThirdRockVentures #VertexPharmaceuticals
    europesays.com/france/64097/

  3. Vertex (VRTX) Wins FDA Expansion For CASGEVY And Advances ALYFTREK In Canada

    Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
    #Canada #ALYFTREK #betathalassemia #CASGEVY #cysticfibrosis #sicklecelldisease #VertexPharmaceuticals
    europesays.com/canada/126364/

  4. AstraZeneca’s $27 Billion TTR Wipeout Hands Alnylam the Market — But Its Own Trial Has the Same Flaw — BigGo Finance

    For AstraZeneca, July 9 was a $27 billion disaster. Its gene-silencing heart drug, eplontersen, had just flopped in…
    #EuropeSays #Britain #Europe #EU #AstraZeneca #Agios #AlnylamPharmaceuticals #Amvutra #anthropic #Biogen #BridgeBioPharma #ClaudeScience #eplontersen #IonisPharmaceuticals #Krenetics #Nucressorin #pfizer #tafamidis #VertexPharmaceuticals
    europesays.com/britain/81031/

  5. Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions

    – Data from pivotal studies of CASGEVY in children ages 5–11 with s…
    #Europe #EU #adolescentpatients #beta-thalassemia #bloodcells #bloodstemcells #European #redbloodcells #sicklecelldisease #TDT #transfusion #VertexPharmaceuticals #whitebloodcells
    europesays.com/europe/66094/

  6. 2 Healthcare Stocks with Exciting Potential and 1 Facing Challenges

    Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has…
    #NewsBeep #News #Healthcare #AU #Australia #CloverHealth #freecashflow #Health #healthcarecompanies #healthcarestocks #MarketCap #returnoncapital #VertexPharmaceuticals
    newsbeep.com/au/702614/

  7. Vertex’s Germany CASGEVY Deal Highlights Growing Non CF Growth Story

    Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
    #Germany #DE #Europe #EU #Europa #CASGEVY #cysticfibrosis #reimbursement #stocktrades #VertexPharmaceuticals
    europesays.com/germany/12629/

  8. As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations-- Sen. Bernie Sanders moves toward another hearing with pharma CEOs --Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March -- See more on our front page news bit.ly/w28kSd #vertexpharmaceuticals #genetherapy #senate #drugpricing #pharmaceos #berniesanders #eisai #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma